Zoetis: Dawn score and attention ranking
Zoetis scores 48 out of 100 on the Dawn Index, built from 4 signals. It ranks #4 of 7 in Pharmaceuticals (S&P 500), #36 of 57 in Health Care (S&P 500), #267 of 455 in S&P 500.
What drives the Zoetis Dawn score?
| Signal | Weight | Score (0 to 100) |
|---|---|---|
| Search scale | 20% | 51 |
| Search momentum | 20% | 46 |
| Site scale | 15% | 47 |
| Site momentum | 10% | 43 |
How does Zoetis compare in Pharmaceuticals (S&P 500)?
| Rank | Brand | Dawn score |
|---|---|---|
| 1 | Johnson & Johnson | 55 |
| 2 | Bristol Myers Squibb | 51 |
| 3 | Pfizer | 49 |
| 4 | Zoetis | 48 |
| 5 | Viatris | 45 |
| 6 | Merck & Co. | 41 |
| 7 | Lilly (Eli) | 35 |
Where do the numbers come from?
Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.